This may not be entirely surprising since EML-ALK activates various downstream signaling molecules including ERK, STAT3, and AKT, which are the key elements in inducing and maintaining stem-like properties for both normal stem cells and cancer stem cells [17, 18, 28, 29, 33]. The gene discussed is STAT3; the disease is cancer.